Daily figures dropped below the 3-lakh mark for the first time in nearly a month.
India’s total tally of Covid-19 cases now stands at 2,49,65,463.
A total of 18,29,26,460 people have been vaccinated so far
New Delhi: Covid numbers brought a heave of relief as the daily figures dropped below the 3-lakh mark for the first time in nearly a month.
Covid numbers brought a heave of relief as the daily figures dropped below the 3-lakh mark for the first time in nearly a month.
In the last 24 hours, 2,81,386 new corona cases were reported — lowest in 25 days, and 4,106 fatalities, the Union Ministry of Health and Family Welfare said.
On May 12, India recorded 4,205 fresh Covid deaths, the highest ever, while on May 7, the country had recorded its highest ever cases of 4,14,188.
India’s total tally of Covid-19 cases now stands at 2,49,65,463 with 35,16,997 active cases and 2,74,390 deaths so far.
Odisha Report |
Number of cases of increase daily infections in the country: 242,034 cases detected in 24 hours, 4,104 deaths.
The number of daily infections in the country has decreased. In 24 hours, 2,41,034 new cases were detected. In one day, 3,691 people were cured, while 4,106 people lost their lives in the epidemic. The total number of infected people in the country has reached 2.65 million. Similarly, the total death toll in the country is 2,3,380. Including the daily healthy rate, 2,11,19,07 people have recovered in the country. There are still 35.14 million people infected and treated in the corona.
The number of cases of Kamila daily infections in the country. In 24 hours, 2,82,034 cases were reported and 4,109 deaths
In the last 24 hours, the number of coronavirus-related infections in the country was 2.91 lakh, while the death toll was 8,108.
As of 9 a.m. Monday, 2,41,38 new coronavirus-infected infections and 4,106 deaths had been recorded across the country as of 9 a.m. Monday, according to the Union Ministry of Health. Including this data, the total number of cases of Covidium infections in India has reached 2,7,45,93 and the number of deaths has reached 2,7,380.
“Nearly 18 crore doses of COVID19 vaccine have been administered in India till date.”
“Around 216 crore doses of vaccines will be manufactured in India between August-December”
New Delhi/Bhubaneswar: NITI Aayog Member (Health), Dr VK Paul on Thursday announced that Russian COVID-19 vaccine- Sputnik V has arrived in India.
Sputnik V production will begin in July and it is estimated that 15.6 crore doses will be manufactured,” said Dr VK Paul, NITI Aayog Member (Health).
While briefing media Paul said, “I’m happy to say that we’re hopeful it’ll be available in the market next week and the sale of the limited supply that has come from Russia, will begin next week.”
“Supply will also follow. Its production will begin in July and it is estimated that 15.6 crore doses will be manufactured in that period,” he added.
Giving a stock of the COVID vaccination drive conducted across different states in the country, Paul said that nearly 18 crore doses of COVID19 vaccine have been administered in India till date. The number of vaccines administered in the US stands at around 26 crores and comparing the figures, India stands in third place.
“We are happy to report that 1/3rd of 45 and above are protected. 45 and above age group contributes to 88% of deaths,” Paul said.
Further clarifying about vaccine manufacturing in the country Paul said, “Around 216 crore doses of vaccines will be manufactured in India between August-December and with this flow, vaccines will be available for all as we move forward.”
The Department of Biotechnology along with other concerned departments, MEA have been in touch with Pfizer, Moderna, Johnson & Johnson from the starting phase. They were officially asked if they’d like to send doses to or manufacture in India.
However, the abroad vaccine manufacturing companies had said that they are working in their own way and they would talk of vaccine availability in Q3, in 2021, informed Paul.
“We are connected to them. I’m hopeful that they’ll step forward to increase availability in India. Any vaccine that is approved by FDA, WHO can come to India. Import license will be granted within 1-2 days. No import license is pending,” clarified Paul.
Meanwhile, Russian scientists said that the phase 3 trial of Sputnik V Covid-19 vaccine is clear, transparent and fully complies with the regulatory standards that exist for the provision of clinical trial data.
The clarification comes after concerns were raised by various scientists over data discrepancies and substandard reporting of interim data of the Coronavirus jab.
A team of scientists from universities in the US, the Netherlands, Italy, France and Russia had earlier flagged concerns over Sputnik V Phase 3 trial, specifically on discrepancies in data sharing, trial protocols, inconsistencies in data reported and numerical results.
“We lack some crucial information, such as the clinical parameters determining suspected Covid-19, what diagnostic protocols were used, when the PCR testing was done, what specific method was used, or how many amplification cycles were used,” said the scientists in the ‘online first’ section of medical journal The Lancet.
They had also pointed out problematic data and lack of transparency in the published Phase 1/2 results.
“Clear and transparent regulatory standards exist for provision of clinical trial data, including data reported in clinical study reports that are considered sufficient for regulatory review and approvals. The reporting of the interim analysis in the Phase 3 Sputnik V clinical trial fully complies with those standards,” said scientists from the Ministry of Health of the Russian Federation in Moscow.
Their reply was also published in the Lancet’s ‘online first’ section.
“It is on this basis that Sputnik V has received registration in 51 countries, which confirms our full transparency and compliance with the regulatory requirements,” they added.
The scientists noted that “the safety and immunogenicity of the Sputnik V vaccine has been confirmed in multiple studies”, including in Argentina, where vaccination with Sputnik V began.
“Authorised in 64 countries with a population of 3.2 billion people, #SputnikV consistently demonstrates safety and efficacy in real world data from Argentina, Mexico, Hungary and other countries,” SputnikV tweeted with a link to the Russian scientists’ reply.
In April, Sputnik V, developed by Russia’s Gamaleya National Center, became the third vaccine to be cleared for use in India, after the Serum Institute of India’s Covishield and Bharat Biotech’s Covaxin were cleared in January.
With an efficacy of 91.6 per cent, Sputnik V was the first vaccine against Covid-19 in the world.
It will be available in markets across the country from early next week, the Union Ministry of Health and Family Welfare (MoHFW) announced on Thursday.
Mucormycosis, also known as black fungus, can turn dangerous if left untreated, doctors said on Friday amid reports of re-emergence of the rare deadly fungal infection among Covid-19 patients.
New Delhi: Mucormycosis, also known as black fungus, can turn dangerous if left untreated, doctors said on Friday amid reports of re-emergence of the rare deadly fungal infection among Covid-19 patients across hospitals in Delhi, Pune and Ahmedabad.
The fungal infection is caused by a group of molds called mucormycetes. These molds live throughout the environment. Mucormycosis mainly affects people who have health problems or take medicines that lower the body’s ability to fight germs and sickness.
The common symptoms associated with the disease include headache, facial pain, nasal congestion, loss of vision or pain in eyes, swelling in cheeks and eyes and black crusts in the nose. The US Centre for Diseases Control and Prevention estimates Mucormycosis with an overall all-cause mortality rate of 54 per cent.
“Mucormycosis can be very dangerous if left untreated can cause mutilating damage to face, nose, eyes with disfigurement and loss of vision and also cause invasive brain infection,” Dr. Mahesh Kumar, Consultant -Internal Medicine, Narayana Health City, Bengaluru, told IANS.
While “Aspergillus and Candida are more common fungal infections, but this infection is dangerous because it involves the sinus and brain and happens to those who are in an immunocompromised state and/or to patients on steroids,” added Dr Vikas Maurya, Director and HOD, Pulmonology, Fortis Hospital, Shalimar Bagh.
According to health experts, Mucormycosis (previously called zygomycosis) has been a cause of disease and death in transplants, ICU and immunodeficient individuals since long. However, it is the rapid increase in numbers seen in unsuspected Covid patients which is a matter of grave concern. Patients who recover from the Covid infection are increasingly being pushed back into the ICUs. Last year, Mucormycisis had caused high mortality with many patients suffering from loss of eyesight, removal of nose and jawbone.
“Mucormycosis is affecting Covid patients more due to prolonged administration of steroids and subsequent immunocompromised state,” Dr Suranjit Chatterjee, Senior Consultant, Department of Internal Medicine, Indraprastha Apollo hospital, New Delhi, told IANS.
“In Covid, patients get steroids and immunity goes down and they may get this infection,” Maurya said.
People with diabetes, those on steroids and humidified oxygen for a long time, and Covid patients with pre-existing comorbidities are the most at risk. Others include patients like those post chemotherapies, those on long-term immunosuppressive drugs.
The Drug Controller General of India, in March this year, gave approval to Mumbai-based bio-pharmaceutical firm Bharat Serums and Vaccines Limited to use anti-fungal medication — Liposomal Amphotericin B or LAmB — as a medical intervention in patients of Mucormycosis.
The risk of this fungus can be avoided by avoiding prolonged use of steroids. The treatment also involves anti-fungal and surgery (if required) to remove the affected area, Chatterjee said.
Judicious use of steroids and immunosuppressive drugs especially in elderly, immunocompromised, cancer and diabetic patients with Covid, are needed during the course of treatment, Kumar advised.
Bhubaneswar: Amid the rising cases of Coronavirus, Odisha government has issued the standard operating procedure (SOP) for the requisition of Tocilizumab for the treatment of COVID-19 patients.
The Additional Chief Secretary (Health), PK Mohapatra has written to all the district collectors, municipal commissioners, CDM and PHOs regarding the SOP for the requisition of Tocilizumab and other drugs to treat Covid positives.
He said that Tocilizumab, as per the Union Health Ministry, may be considered in patients with moderate disease with progressively increasing oxygen requirements and in mechanically ventilated patients not improving despite the use of steroid.
He further said it was observed that the hospitals are submitting requisitions for provision of the Tocilizumab for COVID patients at different hours of the day without adequate information on the patient’s condition making it difficult on the part of the expert committee to recommend its use and supply.
“It has also come to the notice that after receiving the Tocilizumab through government supply, the hospitals have not used the drugs on some patients for whom requisitions were filed. So as a measure to rationalize the supply of Tocilizuniab or appropriate use by needy patients and to avoid the stockpiling of these limitedly available drugs after being issued, the hospital authority (Medical Superintendent/ CMO/ Authorized Medical officer) must submit their requisition for the patients…”
The chairman of the expert committee, on receipt of the copy of the requisition, will review and forward his recommendation/rejection for the issue of the drugs. The hospital with its authorised representative only will receive the drugs from the Odisha State Medical Corporation Limited (OSMCL) and it must return the unutilised drugs to the corporation, Mohapatra added.
Bhubaneswar: Odisha Chief Minister Naveen Patnaik on Thursday requested the Central government to exempt Goods and Services Tax (GST) on purchase of vaccines for COVID-19.
In a letter to Union Finance Minister Nirmala Sitharaman, Patnaik said that the states have been asked to purchase vaccines out of their own resources to cover the 18 to 45 years age group of the population. These purchases attract the GST making the vaccines costly for the states. Hence GST needs to be exempted completely.
“The exemption of the GST will reduce the cost for the States and facilitate our drive towards universal vaccination,” Patnaik mentioned in the letter to the Centre.
The Chief Minister of Odisha has also sought financial assistance to States from Cess and Surcharges collected by the Government of India.
Highlighting that in this long and sustained effort required to fight Covid, it is important that the states are supported so that the entire country fights as one, Patnaik stated in his letter that lack of finances should not affect any state as it might affect the entire country in turn.
“Hence the additional resources raised through various cess and surcharges on petrol, diesel, liquor etc which are exclusively available to the Union Government may be suitably shared with State Governments at this critical juncture,” the CM pointed out in his request to the Union government.
The Chief Minister stressed that sharing of financial assistance with States will strengthen the fight against the pandemic including provision of vaccinations, free treatment, undertaking preventive measures and so on.
“I hope the above suggestions will be examined and urgent necessary action taken in view of the emergency health situation in the country and to strengthen our unified fight against Covid,” he mentioned.
Trinamool Congress (TMC) supremo Mamata Banerjee sworn in as Chief Minister for the third time at Raj Bhavan on Wednesday at 10.45 am after putting a hat-trick of victories in the Bengal assembly elections. The oath-taking ceremony was organized at Raj Bhavan. It was a low-key program given the ongoing Covid-19 pandemic.
In Bengal, Mamata Banerjee got an incredible victory with absolute majority. The people of Bengal have given huge mandate in favor of Didi and cleared the way for her to become the Chief Minister for the third consecutive term.
Political experts say that after this election, Mamata has emerged as a powerful leader who can compete with anyone. The power of Bengal is now in the hands of Didi, but after becoming the Chief Minister, there are many challenges before her.
Rising Corona Graph
The biggest challenge in this front is the growing graph of Corona cases in West Bengal which seems to be out of control. The first and foremost challenge for Mamata Benerjee as a Chief Minister is to control the rising graphs of Corona in the State.
This is the first time the active cases of Corona in West Bengal have crossed the one lakh mark. The election in West Bengal is the one of the main reasons behind the increase in Corona case in the state. Till March 24 i.e. the first phase elections, 628 cases were identified on daily basis in West Bengal. But during the eighth phase election, the Corona picture in the state completely changed. On April 29, till the eighth phase poll, more than 14,000 corona cases started coming up in Bengal in a single day. Realising this fact in her post result press conference, Mamata said, “My first priority is to handle the Covid situation. I appeal to my workers not to hold any victory rally .We can do it later after this Corona situation will get over. Now our main focus should be to handle Corona situation in the state.”
The second challenge is Vaccination. West Bengal has a population of about nine crore but so far, only 23 lakh people have been vaccinated. In such a situation, it is a big challenge for Mamata to vaccinate such a large population.
The third challenge is organised Opposition. The BJP has won 77 Assembly seats in Bengal and the saffron that has emerge as the second largest political party in West Bengal, will sit in the Opposition. For the first time, Mamata will get a tough challenge from the organised opposition in the form of BJP.
Unemployment is a big issue in West Bengal and Mamata was blamed in the past for not addressing this issue as seriously as it has to be. According to the rising Unemployment graph in the state, the rate of unemployment in West Bengal has reached 6.7 percent. After being sworn in as Chief Minister of West Bengal, Mamata will have to work on a plan to reduce unemployment.
The state government will make a big announcement tomorrow regarding the corona. The state government will make a big announcement on the management of the coop. The announcement was made at 10 a.m. tomorrow. So the state government may make some big decisions on the rise of corona. Today, however, Karona set a new record. In the last 24 hours, another 10,413 coronary positives were detected in the state. Yesterday, the number was 8,091, but today it has crossed 10,000. The number of infections has become a headache for people.
However, Khordha district has the highest number of new cases of 10,813 infections. Sixteen cases were reported from Khordha and 1,100 from Sundergarh. Similarly, 427 coronas were detected from Cuttack, 533 from Puri and 511 from Bargarh. Similarly, 42 from Jharsuguda, 426 from Sambalpur, 718 from Nuapadha, 342 from Anugul, 34 from Nabarangpur, 34 from Kalahandi, 332 from Jajpur, 26 from Mayurbhanj, 232 from Ganjam, 232 from Nayagarh, 218 from Kendujhar, 20 from 2004 to 138 103 and 360 from the state pool were positive.
Bhubaneswar: Amid tall claims by the Odisha Health department that the Covid-19 graph is plateauing, allegations on low testing, unavailability of testing kits and mismanagement at testing centres across Odisha have come to fore.
With Odisha constantly witnessing a daily spike of over 6,000 new Covid-19 cases since the last five days, speculations are rife that the graph is flattening due to less testing.
Even though, the Health department is claiming that there is no shortage of testing kits and people are more keen to test themselves, locals of Komna block in Nuapada district have alleged that they couldn’t undergo test even after standing in long queues for hours due unavailability of staff and kits.
“I am standing in queue since the morning to get my Covid test done. After waiting for hours when my turn came up, I was asked to come tomorrow as there was no testing kit left,” said a Nuapada resident.
Surprisingly, Komna hospital authorities have also admitted to the allegations.
“We have a target of 100 antigen and 40 RT-PCR tests. But, we couldn’t meet it due to shorting of testing kits,” said Bhawna Nagpure, Covid In-charge, Komna hospital.
Forget about Nuapada, the scenes in the State Capital is also alarming. People from all age groups are queueing up in Capital Hospital for hours to test themselves. Khordha is also no exception.
“I fear, I would test positive for Covid-19 after standing here in queue for long hours. Nobody knows, who will infect whom,” said a Bhubaneswar resident.
Echoing in similar fashion, a resident of Khordha said, “It is becoming very difficult to move from one counter to another in this scorching heat to get yourself tested. I request the government to come up with a permanent solution to this problem.”
Going by the daily Covid-19 data of last four days, the Health department claims the daily graph is plateauing, and the daily death toll is soaring. Amid allegations of low testing, questions are now being raised on the claims of State government.
Meanwhile, refuting the allegations the director of Public Health Niranjan Mishra claimed that there is no shortage of testing kits in the State and more emphasis is being given to targeted sampling.
“The demand for testing has increased. There are sufficient testing kits at all testing centres,”
Bhubaneswar: The daily Covid-19 new cases which was plateauing between 6,000 and 6500 for the last five days, today witnessed an exponential jump crossing 8,000-mark.
The new positive cases which stood at 6073 yesterday, have shot up to 8386 in the last 24 hours. With today’s figure, the cumilative caseload has gone up to 42,8515 in the State.
Of the 8386 new case, 4781 cases were from quarantine while 3605 were local contacts. As many as 4089 patients have recovered during the period pushing total recovery tally to 371200. The active cases stand at 55245 in the State. Apart from the record spike in new positive case, the State also witnessed a distressing report of 10 fatalities due to the deadly various in last 24 hours. The cumulative death tally in State mounted to 2017.
Puri and Rayagada districts reported maximum three casualties each while Boudh, Ganjam, Khordha, and Sundergarh registered one death case each.
Sundergarh remains at the second spot with 933 cases while Cuttack stood at third position at 496 followed by Jharsuguda which reported 433 cases.
Similarly, Nabarangpur witnessed a daily spike of 388 cases and Bolangir saw 358 positive cases. Angul and Sambalpur districts posted 347, 307 cases respectively.
The districts which witnessed below 300 marks in the daily new cases are Mayurbhabhanj (289), Jajpur (270), Puri (259), Bargarh (257), Nuapada (233), Ganjam (209), Balasore (202).
Keonjhar, Jagatsinghpur, Kalahandi, Nayagarh recorded below 200 mark other remaining districts saw less than 100 daily positive cases. With 21 new cases Dhenkanal remained in the bottom in the row.
Bhubaneswar: Amid shortage of medical oxygen across the country, Odisha, so far, has sent 90 tankers of the life-saving gas to other States, said Crime Branch ADG Yashwant Jethwa on Tuesday.
Odisha has been sending O2 tankers to neighbouring Andhra Pradesh, Telangana, Tamil Nadu and Haryana as these States are grappling with acute shortage of the gas for the treatment of Covid patients, Jethwa who is supervising the supply added.
“90 tankers carrying 1676 MT medical oxygen has been sent from Odisha. Special arrangements have been made so that the gas-tankers can reach hospital with ease,” the top cop said.
Arrangements have been made to fill the empty cylinders and a special corridor has been formed for the smooth movement of the these tankers, he informed.
Odisha Police is in contact with their counterparts in other States so that the life-saving can be easily sent to maximum hospitals.
Notably, Odisha is producing 6,700 tons of oxygen daily at its 24 steel plants. While Tata Plant in Kalinga Nagar, Utkal Alumina, Jindal and Bhushan plants are producing 6000 tons, the remaining 700 tons are being produced by other plants.
Last week, Delhi Chief Minister Arvind Kejriwal had extended his gratitude towards Odisha for supplying oxygen during the ongoing fight against COVID-19.
Through a tweet, Kejriwal also thanked Odisha Chief Minister Naveen Patnaik who assured him of all support in facilitating lifting of oxygen quota from Odisha. Patnaik has engaged a special officer on the job, the Delhi CM had tweeted.